Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03413644 · ClinicalTrials.gov registry record
Evaluation of ClearLLab Leukemia and Lymphoma Panels
A clinical trial of Leukemia/Lymphoma, sponsored by Beckman Coulter.
- Completed
- Registry status
- 482
- Enrollment target
- 4
- Study locations
NCT03413644: Completed study of Leukemia/Lymphoma, sponsored by Beckman Coulter.
NCT03413644 is a study of Leukemia/Lymphoma that has completed, run by Beckman Coulter. The registered enrollment target is 482 participants. The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03413644, a study of Leukemia/Lymphoma, has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 482 participants
- Enrollment target
- 4
- Study locations
Study Summary
Multi-center study of specimens from subjects presenting to the flow cytometry laboratory as part of their standard of care for hematological diseases work-up.
Primary Outcome
Presence or absence of an abnormal phenotype detected using the ClearLLab Panels vs. the clinical outcome of "Hematologically Malignant" or "Hematologically Non-Malignant" from the same subject
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Flow Cytometry
Study Locations (4)
Florida
- NeoGenomics Laboratories, Inc. - Fort Myers
Alberta
- Calgary Laboratory Services - Calgary
Ontario
- London Health Sciences Center - London
Other
- Munich Leukemia Laboratory - Munich
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 482 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2018-04-27 |
What the finished NCT03413644 record still lists
NCT03413644 is an observational study that tracks outcomes without assigning an intervention. The registered 482 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Leukemia/Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which Flow Cytometry is the first listed.
NCT03413644 reports a single indexed study location in Florida, Alberta, Ontario.
Frequently Asked Questions
What is clinical trial NCT03413644 about?
NCT03413644 is a clinical study titled "Evaluation of ClearLLab Leukemia and Lymphoma Panels". Multi-center study of specimens from subjects presenting to the flow cytometry laboratory as part of their standard of care for hematological diseases work-up.
What is the current status of trial NCT03413644?
This trial is currently completed. The enrollment target is 482 participants. The study started on 2017-11-14. Estimated completion is 2018-04-27.
What conditions does trial NCT03413644 study?
This clinical trial studies the following conditions: Leukemia/Lymphoma.
What interventions are being tested in trial NCT03413644?
The interventions under investigation include: Flow Cytometry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03413644?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03413644 being conducted?
This trial has 4 study locations across Florida, Alberta, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia/Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI